Trial intelligence / Profile preview

Marcaine for Postoperative Pain in TVT-O

NCT03479996Completed

Sponsor
Barzilai Medical Center
Start
Nov 2018
Primary completion
Jun 2020
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of bupivacaine in postoperative pain (2 arms), sponsored by Barzilai Medical Center. Primary endpoint: Leg pain intensity at 24 hours. Started Nov 2018; status: completed.

02

Drugs

bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT03479996.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03479996.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call